SCOPUS 정보 검색 플랫폼

Anti-Cancer Drugs

Volumn 13, Issue 2, 2002, Pages 173-176

Individualized long-term chemotherapy for recurrent ovarian cancer after failing high-dose treatment

(4) Breidenbach, Martina a Rein, Daniel T a Mallmann, Peter a Kurbacher, Christian M a

a UNIVERSITY OF COLOGNE (Germany)

Author keywords

ATP tumor chemosensitivity assay; Long term chemotherapy; Recurrent ovarian cancer

Indexed keywords

ADENOSINE TRIPHOSPHATASE; CARBOPLATIN; CISPLATIN; DOXORUBICIN; ETOPOSIDE; GEMCITABINE; MELPHALAN; PACLITAXEL; TREOSULFAN;

ADULT; ARTICLE; ASSAY; CANCER CHEMOTHERAPY; CANCER GROWTH; CANCER REGRESSION; CANCER SURVIVAL; CASE REPORT; CHEMOSENSITIVITY; CLINICAL PROTOCOL; DEVICE; DRUG MEGADOSE; FEMALE; HUMAN; LONG TERM CARE; OVARY CANCER; POSTOPERATIVE CARE; PREVALENCE; PRIORITY JOURNAL; RECURRENT CANCER; RELAPSE; SURVIVAL TIME; TREATMENT PLANNING;

ADENOCARCINOMA; ADULT; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BUSULFAN; CISPLATIN; DEOXYCYTIDINE; DOXORUBICIN; FEMALE; HUMANS; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; OVARIAN NEOPLASMS; TREATMENT FAILURE;

EID: 0036189812 PISSN: 09594973 EISSN: None Source Type: Journal
DOI: 10.1097/00001813-200202000-00010 Document Type: Article

Times cited : (9)

References (10)

1
- 0032964713
- Treatment of refractory and recurrent ovarian cancer
- (1999) Semin Oncol , vol.26 , pp. 8-14
- Alberts, D.S.¹

2
- 0028631080
- Statement ovarian cancer: Screening, treatment, and follow-up
- (1994) Gynecol Oncol , vol.55 , pp. 4-14

3
- 0028846061
- Chemosensitivity testing of human tumors using a microplate adenosine triphosphate assay: Clinical correlation for cisplatin resistance of ovarian carcinoma
- (1995) Cancer Res , vol.55 , pp. 5276-5282
- Andreotti, P.E.¹ Cree, I.A.² Kurbacher, C.M.³

4
- 0003212661
- Treosulfan and Gemcitabine in heavily pretreated patients with breast and ovarian cancer: Laboratory study and clinical pilot trial of the ISCO Clinical Study Group
- (2001) Proc Am Soc Clin Oncol , vol.20 , pp. 2500
- Grecu, O.¹ Kurbacher, C.M.² Mallmann, P.³ Bruckner, H.W.⁴ Cree, I.A.⁵

5
- 0027441559
- Decreased efficacy of cyclophosphamide, epirubicin and 5-fluorouracil in metastatic breast cancer when reducing treatment duration from 18 to 6 months
- (1993) Eur J Cancer , vol.29 , pp. 527-530
- Ejlertsen, B.¹ Pfeiffer, P.² Pederson, D.³

6
- 0029560004
- The role of paclitaxel in the management of coelomic epithelial carcinoma of the ovary: A review with emphasis on the Gynecologic Oncology Group experience
- (1995) Semin Oncol , vol.22 , pp. 23-31
- Thigpen, T.¹ Vamce, R.B.² McGuire, W.P.³

7
- 0028020890
- Phase II study of gemcitabine in previously platinum treated ovarian cancer
- (1994) J Natl Cancer Inst , vol.85 , pp. 1530-1533
- Lund, B.¹ Hansen, O.P.² Theilade, K.³

8
- 0031894188
- Prolonged oral etoposide as second line therapy for platinum resistant and platinum sensitive ovarian cancer. A Gynecologic Oncology Group study
- (1998) J Clin Oncol , vol.16 , pp. 405-410
- Rose, P.G.¹ Blessing, J.A.² Mayer, A.R.³

9
- 0030900145
- Topotecan versus paclitaxel for the treatment of recurrent epithelial ovarian cancer
- (1997) J Clin Oncol , vol.15 , pp. 2183-2193
- Ten Bokkel Huinink, W.¹ Gore, M.² Carmichael, J.³

10
- 0008612450
- A prospective clinical trial on individualized chemotherapy for recurrent ovarian cancer selected by the ex vivo ATP tumor Chemosensitivity assay
- (1999) Proc Am Soc Clin Oncol , vol.18 , pp. 358
- Kurbacher, C.M.¹ Bruckner, H.W.² Cree, I.A.³ Andreotti, P.A.⁴ Janat, M.M.⁵

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.